El Hospital Costa del Sol es un centro hospitalario gestionado por la Consejería de Salud de la Junta de Andalucía a través de la Agencia Sanitaria Costa del Sol, este siendo una empresa pública, ubicado a unos 7 km al este de la ciudad española de Marbella, junto a la autovía A-7.

During the past decade, Hospital Costa del Sol conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 16 clinical trials were completed, i.e. on average, 23.9% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 9 clinical trials were completed. i.e. 26.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Costa del Sol" #1 sponsor was "Celgene" with 9 trials, followed by "Fundacion SEIMC-GESIDA" with 5 trials sponsored, "PETHEMA Foundation" with 5 trials sponsored, "Centro Nacional de Investigaciones Oncologicas CARLOS III" with 4 trials sponsored and "Gilead Sciences" with 4 trials sponsored. Other sponsors include 61 different institutions and companies that sponsored additional 54 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Costa del Sol" #1 collaborator was "Hospital Costa del Sol" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator, "Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia" with 2 trials as a collaborator and "Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud" with 2 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Costa del Sol" are "HIV Infections" (6 trials), "Multiple Myeloma" (5 trials), "Advanced Prostate Cancer" (4 trials), "HIV-1 Infection" (4 trials) and "Perioperative Care" (3 trials). Many other conditions were trialed in "Hospital Costa del Sol" in a lesser frequency.

Most popular intervention types in "Hospital Costa del Sol" are "Drug" (61 trials), "Other" (11 trials), "Device" (5 trials), "Biological" (4 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lenalidomide" (8 trials), "Placebo" (7 trials), "Rituximab" (6 trials), "Dexamethasone" (5 trials) and "ABC/3TC" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Costa del Sol" are 84 trials for "All" genders, 5 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 30 active trials in "Hospital Costa del Sol". 2 are not yet recruiting, 16 are recruiting, 11 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 44 completed trials in Hospital Costa del Sol, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Costa del Sol, 3 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 5 trials that are defined as “Not Applicable".

Hospital Costa del Sol has several departments that took part in Clinical trials: "Hospital Costa del Sol; Servicio de Hematologia" - 3 trials, "Hospital Costa del Sol; Servicio de Oncologia" - 2 trials